
    
      This is a two arm, randomized, double-blind, placebo controlled cohort study to determine the
      protective efficacy of a monthly 2 day treatment course of Dihydroartemisinin-Piperaquine
      (DP) in adult volunteers in malaria endemic areas of Cambodia.
    
  